BICCIATO, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 29.637
EU - Europa 12.969
AS - Asia 12.023
SA - Sud America 1.962
AF - Africa 287
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 11
Totale 56.950
Nazione #
US - Stati Uniti d'America 29.215
IT - Italia 3.893
GB - Regno Unito 3.565
SG - Singapore 3.426
CN - Cina 3.303
HK - Hong Kong 1.614
VN - Vietnam 1.464
BR - Brasile 1.450
SE - Svezia 1.072
DE - Germania 851
FI - Finlandia 730
FR - Francia 612
UA - Ucraina 534
RU - Federazione Russa 521
TR - Turchia 408
KR - Corea 344
NL - Olanda 327
ID - Indonesia 277
IN - India 260
BG - Bulgaria 237
CA - Canada 182
JP - Giappone 177
AR - Argentina 146
MX - Messico 133
BD - Bangladesh 132
EC - Ecuador 104
CO - Colombia 91
IQ - Iraq 91
ZA - Sudafrica 78
PL - Polonia 71
ES - Italia 69
IE - Irlanda 68
AE - Emirati Arabi Uniti 63
PK - Pakistan 59
AT - Austria 56
BE - Belgio 49
TW - Taiwan 47
PH - Filippine 46
MA - Marocco 44
CL - Cile 43
AU - Australia 39
LT - Lituania 39
CH - Svizzera 37
VE - Venezuela 37
IR - Iran 35
PY - Paraguay 34
UZ - Uzbekistan 32
PT - Portogallo 30
CZ - Repubblica Ceca 29
DZ - Algeria 29
TH - Thailandia 29
RO - Romania 28
PA - Panama 27
PE - Perù 27
EG - Egitto 26
TN - Tunisia 26
MY - Malesia 23
SA - Arabia Saudita 21
DK - Danimarca 20
GR - Grecia 20
SI - Slovenia 20
KE - Kenya 19
NZ - Nuova Zelanda 19
NP - Nepal 18
OM - Oman 17
AZ - Azerbaigian 16
JO - Giordania 16
UY - Uruguay 16
KZ - Kazakistan 15
CR - Costa Rica 14
ET - Etiopia 13
SK - Slovacchia (Repubblica Slovacca) 13
BZ - Belize 12
DO - Repubblica Dominicana 12
JM - Giamaica 12
IL - Israele 11
BH - Bahrain 10
BO - Bolivia 10
LB - Libano 10
NO - Norvegia 10
RS - Serbia 10
AL - Albania 9
BY - Bielorussia 9
SY - Repubblica araba siriana 9
LU - Lussemburgo 8
NG - Nigeria 8
TZ - Tanzania 8
KG - Kirghizistan 7
PS - Palestinian Territory 7
AM - Armenia 6
MD - Moldavia 6
QA - Qatar 6
TT - Trinidad e Tobago 6
AO - Angola 5
EU - Europa 5
HN - Honduras 5
KH - Cambogia 5
MT - Malta 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
Totale 56.856
Città #
Fairfield 3.689
Ashburn 2.931
Southend 2.403
Singapore 2.184
Santa Clara 2.183
Woodbridge 1.886
Hong Kong 1.563
Chandler 1.536
Houston 1.521
Seattle 1.403
Cambridge 1.295
Wilmington 1.216
Ann Arbor 1.011
Jacksonville 930
Hefei 909
Dearborn 890
Beijing 733
San Jose 685
Nyköping 637
London 631
Helsinki 542
Ho Chi Minh City 452
Council Bluffs 439
The Dalles 433
Milan 358
Los Angeles 355
Hanoi 344
Chicago 343
San Diego 343
Modena 322
Seoul 311
Princeton 261
Izmir 248
New York 229
Sofia 227
Jakarta 222
Des Moines 202
Eugene 184
Rome 183
Lauterbourg 176
Buffalo 134
Moscow 133
Shanghai 131
Salt Lake City 123
São Paulo 113
Tokyo 99
Phoenix 96
Dallas 90
Redwood City 86
Bologna 83
Munich 78
Columbus 77
Falls Church 76
Dong Ket 75
Da Nang 70
Haiphong 67
Orem 64
Berlin 63
Frankfurt am Main 62
Bremen 61
Boardman 60
Guangzhou 59
Dublin 56
Elk Grove Village 56
Florence 56
Toronto 53
Padova 51
Palermo 51
Naples 50
Verona 49
Rio de Janeiro 48
Norwalk 47
Tampa 46
Chennai 44
Turin 42
Amsterdam 41
Brussels 41
Kent 41
Quito 41
San Francisco 40
Nuremberg 39
Bari 38
Nanjing 38
Paris 38
Baghdad 37
Brasília 36
Cardiff 36
Redondo Beach 36
Sterling 36
Grafing 35
Denver 33
Brooklyn 32
Charlotte 32
Manchester 32
Warsaw 32
Miami 31
Johannesburg 30
Parma 30
Miano 29
Tashkent 29
Totale 39.842
Nome #
Matrici di DNA per lo studio dell’espressione genica 1.229
Role of YAP/TAZ in mechanotransduction 1.209
Regeneration of the entire human epidermis using transgenic stem cells 832
Genomica e proteomica computazionale 761
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 694
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 508
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 423
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 400
Comparison of computational methods for Hi-C data analysis 398
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 395
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 395
APTANI2: Update of aptamer selection through sequence-structure analysis 383
MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells 373
A locally adaptive statistical procedure (LAP) to identify differentially expressed chromosomal regions 367
Computational methods for analyzing genome-wide chromosome conformation capture data 359
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 358
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 358
Aerobic glycolysis tunes YAP/TAZ transcriptional activity 357
UCbase 2.0: ultraconserved sequences database (2014 update) 347
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response. 347
Genomic expression during human myelopoiesis 344
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 342
Algorithm for automatic genotype calling of single nucleotide polymorphisms using the full course of TaqMan real-time data 333
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 329
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma 328
APTANI: a computational tool to select aptamers through sequence-structure motif analysis of HT-SELEX data 323
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis 320
A MicroRNA targeting dicer for metastasis control 319
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 318
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 317
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 315
Chromosome positioning in interphase nuclei of hematopoietic stem cell and myeloid precursor 312
A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells 308
Aryl hydrocarbon receptor control of a disease tolerance defence pathway 300
Mining of Biological Data I: Identifying Discriminating Features via Mean Hypothesis Testing 299
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients 299
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth 296
A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets. 295
Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease 293
Transcriptional profiling of human bronchial epithelial cell BEAS-2B exposed to diesel and biomass ultrafine particles 293
Acute Leukemia Subclassification: A Marker Protein Expression Perspective 292
A-MADMAN: annotation-based microarray data meta-analysis tool. 291
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 291
HGM 2010 Programme / Abstract 290
Glucocorticoid receptor signalling activates YAP in breast cancer 289
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 287
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma 287
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 286
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation 286
Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations 285
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 285
The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle 284
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 284
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors 282
A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer 281
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 280
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 278
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 278
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy 278
Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering 277
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties 276
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ 275
Identification of new genomic lesions in childhood ALL without known genetic aberrations: A microarray study of gene expression and genotype data. 273
A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer 271
A gene expression signature associated with survival in metastatic melanoma 270
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma 270
High NRF2 levels correlate with poor prognosis in colorectal cancer patients and with sensitivity to the kinase inhibitor AT9283 in vitro 270
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells 268
LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 268
Mining of Biological Data II: Assessing Data Structure and Class Homogeneity by Cluster Analysis 267
Aging: A portrait from gene expression profile in blood cells 266
Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification 265
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 265
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 262
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 262
Computational analysis of hi-c data 261
Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia 260
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 260
Critical analysis of transcriptional and post-transcriptional regulatory networks in multiple myeloma 259
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 259
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 258
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 258
Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP 258
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 255
Notch is a direct negative regulator of the DNA-damage response 255
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 254
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs) 253
Pattern identification and classification in gene expression data using an autoassociative neural network model 252
Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. 252
Transcriptional features of multiple myeloma patients with chromosome 1q gain 251
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis 250
F-actin dynamics regulates mammalian organ growth and cell fate maintenance 250
popsicleR: a R Package for pre-processing and quality control analysis of single cell RNA-seq data 250
A Batch-Type System for Large-Scale Solid-Phase Oligonucleotide Synthesis 249
TRANSCRIPTOME ANALYSIS IN THE INTERACTION BRACHYPODIUM – PUCCINIA BRACHYPODII 249
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells 248
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus 247
GDA, a web-based tool for Genomics and Drugs integrated analysis 246
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion 245
Computational methods for the integrative analysis of single-cell data 245
Totale 32.819
Categoria #
all - tutte 215.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021994 0 0 0 0 0 0 0 0 0 0 497 497
2021/20224.971 406 547 489 240 136 432 263 286 505 427 705 535
2022/20234.530 533 432 384 383 508 762 102 450 558 64 186 168
2023/20243.015 142 172 211 227 471 270 247 391 115 152 139 478
2024/20259.007 335 97 116 577 1.694 1.233 611 635 944 677 1.063 1.025
2025/202616.231 1.124 738 1.619 1.827 2.081 1.448 2.121 1.190 1.946 1.635 502 0
Totale 57.505